| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |